Skip to main content
Equibles

MARSHALL WACE, LLP

Position in NSPR — InspireMD, Inc.

CIK 1318757 LONDON, X0
Back to NSPR Full portfolio

Position in NSPR

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,302,283
-$1,730,177 QoQ
Shares Held
1,860,405
0.0% QoQ
Ownership
4.00%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#6
of 37 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in NSPR Over Time

Shares Held

Position Value (USD)

Position in Medical Devices

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $951,017,652 across 59 Medical Devices names. NSPR ranks #39 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABT
Abbott Laboratories
 5,542,438 $502,920,823
2 BSX
Boston Scientific Corp
 2,414,223 $103,039,037
3 GKOS
GLAUKOS Corp
 314,804 $43,997,006
4 DXCM
Dexcom Inc
 532,804 $35,884,349
5 EW
Edwards Lifesciences Corp
 344,361 $31,150,895
6 PEN
Penumbra Inc
 90,520 $28,581,689
7 SYK
Stryker Corp
 51,116 $16,093,361
8 GMED
Globus Medical Inc
 188,541 $14,896,623

All Filings in NSPR

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,302,283 1,860,405
2026-03-31 $3,032,460 1,860,405
2025-12-31 $3,311,520 1,860,405
2025-09-30 $4,483,576 1,860,405
2025-06-30 $4,223,119 1,860,405
2025-03-31 $5,004,489 1,860,405
2024-12-31 $4,892,865 1,860,405
2024-09-30 $4,985,885 1,860,405
2024-06-30 $4,651,012 1,860,405
2024-03-31 $4,409,159 1,860,405
2023-12-31 $5,227,738 1,860,405
2023-09-30 $6,083,524 1,860,405
2023-06-30 $4,669,616 1,860,405